Drug Shortage Report for SCOPOLAMINE HYDROBROMIDE INJECTION
Report ID | 110834 |
Drug Identification Number | 02242810 |
Brand name | SCOPOLAMINE HYDROBROMIDE INJECTION |
Common or Proper name | Scopolamine Hydrobromide Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SCOPOLAMINE HYDROBROMIDE |
Strength(s) | 0.4MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10 x 1mL vial /fiole |
ATC code | N05CM |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-04-02 |
Estimated end date | 2020-06-08 |
Actual end date | 2020-06-05 |
Shortage status | Resolved |
Updated date | 2020-06-09 |
Company comments | On Allocation (Covid-19) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-04-03 | English | Compare |
v2 | 2020-04-03 | French | Compare |
v3 | 2020-06-05 | English | Compare |
v4 | 2020-06-05 | French | Compare |
v5 | 2020-06-09 | English | Compare |
v6 | 2020-06-09 | French | Compare |
Showing 1 to 6 of 6